Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lumiera Health Inc V.NHP.H

Lumiera Health Inc. is a Canadian company that specializes in the development and commercialization of natural health products. Its brands consist of Holizen Laboratories, Awaye pain relief cream, and Bazzzics. Through its Holizen Laboratories division, the Company sells both oral and topical formulations to help manage a range of therapeutic needs, including a new generation of natural sleep... see more

Recent & Breaking News (TSXV:NHP.H)

Lumiera announces the results of its annual meeting

PR Newswire July 6, 2021

Lumiera Health announces proposed $1.3 Million Private Placement

Canada NewsWire June 18, 2021

Lumiera Health expands distribution of Bazzzics(TM) sleep-aid products nationally

Canada NewsWire May 20, 2021

Lumiera Health begins sales of Awaye(TM) pain relief cream and launches direct-to-consumer e-Commerce platform

Canada NewsWire April 15, 2021

9315-4466 Québec Inc. Disposes of Shares in Lumiera Health Inc.

Canada NewsWire March 16, 2021

Shares for Debt Settlement

Canada NewsWire March 12, 2021

Carlos Ponce is Appointed New Chief Executive Officer

Canada NewsWire February 4, 2021

Lumiera Announces Completion of the Sales of Its Non-Core Asset Celext07

Canada NewsWire January 29, 2021

/C O R R E C T I O N from Source -- Lumiera Health Inc./

Canada NewsWire January 29, 2021

Lumiera Monetizes Its Non-Core Asset with the Sale of Celext07

Canada NewsWire January 4, 2021

Lumiera announces the commercial launch of Bazzzics(TM), a natural, over-the-counter product lines, targeting sleep disorders and anxiety

Canada NewsWire December 16, 2020

Lumiera Announces the Signature of a Sale Representation Agreement Covering Quebec and Canada for its Holizen Portfolio

Canada NewsWire November 9, 2020

Mondias Announces Name Change following Acquisition of Lumiera Acquisition and Closing of Private Placement

Canada NewsWire November 4, 2020

Mondias Announces Completion of Lumiera Health Acquisition

Canada NewsWire October 28, 2020

Mondias announces amendments to the terms of previously announced acquisition of Lumiera Health Innovation Inc.

Canada NewsWire October 23, 2020

Mondias announces Debt Conversion Settlements

Canada NewsWire September 23, 2020

Mondias announces the results of its annual meeting

Canada NewsWire September 14, 2020

Mario Paradis is named Interim CEO

Canada NewsWire August 5, 2020

IIROC Trading Resumption - NHP

Canada NewsWire July 23, 2020

Tetra and Mondias jointly announce the acquisition of Tetra's subsidiary, Lumiera, by Mondias to create a new growth platform

Canada NewsWire July 23, 2020